titanium-prepared platelet-rich fibrin
PreclinicalBiologic
titanium-prepared platelet-rich fibrin is one of 30 biologic programs targeting Wound Healing. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
29
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
133 competitors in Wound Healing
#DrugCompanyPhaseTrials
1Avastin
BBio-Thera Solutions
Phase 3
Januvia
ZZydus Therapeutics Inc.
Phase 3
Glucophage
EMD SeronoPhase 3
Inderal
WWyeth-Lederle Vaccines
Phase 3
Growth Hormone
PfizerPhase 3
Vaseline
MMassachusetts General Hospital
Phase 3
Oxandrolone
PPar Pharmaceutical, Inc.
Phase 3
Becaplermin
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3
Oxandrolone and Propranolol
TThe University of Texas Medical Branch, Galveston
Phase 3
Nicorette
PfizerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- SSaglik Bilimleri Universitesi